Other
Propranolol
0
Pipeline Programs↗
5
Active Trials↗
6
Companies Involved↗
Propranolol is an early-stage landscape with 0 programs across 6 companies. The most active players are Boehringer Ingelheim, Mylan Pharmaceuticals Inc, Par Pharmaceutical, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
52
clinical trials
Completed24 · 46%
Unknown status14 · 27%
Terminated6 · 12%
Recruiting3 · 6%
Withdrawn3 · 6%
Enrolling by invitation1 · 2%
Other1 · 2%
Clinical Trials
Trial Activity
52 trials
Propranolol Treatment for Postoperative Chylothorax
Recruiting·—·Phase 1/2·NCT06833320·50 enrolled
Neurobehavioral Substrates of Propranolol's Effects on Drug Cue Reactivity
Completed·—·Phase 4·NCT03309943·44 enrolled
Influence of Propranolol on Conditioned Pain Modulation
Completed·—·N/A·NCT02808611·25 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)